You’re Going to Feel a Small(er) Pinch: Theranos’s Disruptive Innovation in Blood Testing and Lab Diagnostics

by Ryan Harbison | 1Q 2015 | IN-3519

Theranos, based in Palo Alto, California, is using microfluidic technology and streamlined business processes to try and disrupt the nearly US$70 billion laboratory diagnostics industry, but can it go against testing giants Quest Diagnostics and LabCorp?

You must be a subscriber to view this Insight.

To find out more about subscribing:
Contact a representative about purchasing options.